ARWR vs TGTX: stock comparison and AI forecast
Arrowhead Pharmaceuticals, Inc. (ARWR) and Tg Therapeutics, Inc. (TGTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ARWR Arrowhead Pharmaceuticals, Inc.
- Market Cap
- $8.12B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
TGTX Tg Therapeutics, Inc.
- Price
- $57.98 +34.8% · 6M
- Market Cap
- $9.20B
- P/E Ratio
- 21.9x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- TGTX is 1.1 times larger than ARWR by market capitalization ($9.20B against $8.12B).
- ARWR carries 3.54 times debt per unit of equity, against 1.71 times for TGTX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ARWR | TGTX |
|---|---|---|
| Market Cap | $8.12B | $9.20B |
| P/E Ratio | – | 21.88x |
| P/B Ratio | 17.43x | 15.23x |
| EPS | $-1.47 | $2.65 |
| Book Value/Share | $3.30 | $3.81 |
| Revenue/Share | $6.63 | $5.04 |
| FCF/Share | $-0.53 | $0.11 |
Profitability & Margins
| Metric | ARWR | TGTX |
|---|---|---|
| ROE | – | 73.1% |
| ROA | – | 26.9% |
| ROIC | -12.4% | 9.9% |
| Gross Margin | – | 82.4% |
| Operating Margin | -24.2% | 17.1% |
| Net Margin | – | 55.2% |
| EBT Margin | -26.9% | 12.7% |
| Tax Rate | -8.0% | -334.5% |
Financial Health
| Metric | ARWR | TGTX |
|---|---|---|
| Current Ratio | 5.90x | 4.27x |
| Quick Ratio | – | 3.72x |
| D/E Ratio | 3.54x | 1.71x |
| Financial Leverage | 4.54x | 2.71x |
| Interest Coverage | -2321.4x | 1.2x |
| Working Capital | $1.39B | $877M |
Cash Flow
| Metric | ARWR | TGTX |
|---|---|---|
| Operating Cash Flow | -$59M | $18M |
| Free Cash Flow | -$75M | $17M |
| Capital Spending | -$16M | -$490K |
| OCF Growth YoY | -370.3% | – |
| FCF/Sales | -8.0% | 2.2% |
| CapEx/Sales | 1.7% | 0.1% |
Operational Efficiency
| Metric | ARWR | TGTX |
|---|---|---|
| Asset Turnover | 0.44x | 0.49x |
| Receivables Turnover | 109.4x | 2.0x |
| Inventory Turnover | – | 0.9x |
| Fixed Assets Turnover | 2.5x | – |
| Days Sales Outstanding | 3 days | 183 days |
| Days Inventory | – | 383 days |
Income Statement
| Metric | ARWR | TGTX |
|---|---|---|
| Total Revenue | $936M | $800M |
| Operating Income | -$226M | $136M |
| Net Income | – | $441M |
| R&D Expense | $723M | $226M |
| SG&A Expense | – | $296M |
| Cost of Goods Sold | – | $141M |
Dividend & Shareholder Information
| Metric | ARWR | TGTX |
|---|---|---|
| Shares Outstanding | 141M | 159M |
| Net Income Growth | – | 630.2% |
| EPS Growth | – | 846.4% |
ARWR vs TGTX: stock comparison and AI forecast
Which is bigger, ARWR or TGTX?
TGTX is 1.1 times larger than ARWR by market capitalization ($9.20B against $8.12B).
Which one does Intratio's AI model rank higher, ARWR or TGTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.